Skip to main content
    D

    Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

    Official site

    FINANCIAL SERVICES • SHELL COMPANIES • NASDAQ

    $10.90
    +0.00 (+0.00%)

    Market Cap: $264.62M

    Last updated: Nov 17, 2026 at 4:00 PM ET

    Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a market cap of $264.62M and an enterprise value of $264.60M. Its share count is down 27.57% from a year earlier.

    Total Valuation

    Enterprise value is 0.01% below the market cap, as cash exceeds debt.

    Market Cap$264.62M
    Enterprise Value$264.60M
    Close (Nov 17, 2026)$10.90

    Key Dates

    Last Earnings DateJun 30, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 21.21% in the quarter ended Sep 30, 2026 and grew 68.30% a year over 2 years.

    Shares Outstanding24.28M
    Shares Change (YoY)-27.57%
    Shares Change (QoQ)-21.21%
    Share Count Growth (2Y CAGR)+68.30%

    Price Statistics

    The stock is up 5.55% over 52 weeks and trades 0.28% above its 50-day average.

    Beta (1Y)0.00
    52-Week Change+5.55%
    1-Month Change+0.28%
    3-Month Change+1.68%
    6-Month Change+3.02%
    Total Return (1Y)+5.55%
    Return vs SPY (1Y)-5.99%
    Max Drawdown (1Y)-0.46%
    Sharpe Ratio (1Y)2.94
    Correlation with SPY (1Y)-0.01
    50-Day Average$10.87
    200-Day Average$10.66
    52-Week Range$10.32 to $10.91
    RSI (14 Days)68.3
    Average Volume (20 Days)14.37K

    Financial Position

    Current assets cover 0.02x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio0.02x
    Quick Ratio0.02x
    Debt / Equity0.00x

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Operating Income-$2.47M
    Pretax Income$5.16M
    Net Income$5.16M
    Reported EPS (TTM)$0.19

    Trailing 12 months through Sep 30, 2026.

    Balance Sheet

    Cash and Equivalents$17.01K
    Total Debt$0
    Net Cash$17.01K
    Net Cash Per Share$0.00
    Working Capital-$2.21M
    Shareholder Equity-$8.40M
    Total Assets$147.46M
    Total Liabilities$8.45M

    Balance sheet as of Sep 30, 2026.

    Cash Flow

    Operating Cash Flow-$539.31K
    FCF Per Share-$0.02

    Trailing 12 months through Sep 30, 2026.

    Dividends and Yields

    DMAA does not pay a dividend.

    Earnings Yield1.71%
    Buyback Yield0.00%
    Shareholder Yield0.00%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About DMAA

    What is DMAA's market cap?

    Drugs Made In America Acquisition Corp. Ordinary Shares has a market cap of $264.62M. Its enterprise value, which adds debt and subtracts cash, is $264.60M.

    What is DMAA's P/E ratio?

    Drugs Made In America Acquisition Corp. Ordinary Shares has a trailing P/E ratio of 58.6x.

    How many shares of DMAA are outstanding?

    Drugs Made In America Acquisition Corp. Ordinary Shares has 24.28M shares outstanding. The count is down 27.57% from a year earlier.

    Does DMAA pay a dividend?

    No. Drugs Made In America Acquisition Corp. Ordinary Shares does not pay a dividend.

    How much debt does DMAA have?

    Drugs Made In America Acquisition Corp. Ordinary Shares has $0 of total debt and $17.01K of cash and equivalents, a net cash position of $17.01K.